Legal Representation
Attorney
LEON R YANKWICH
USPTO Deadlines
Application History
8 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Aug 26, 2002 | TCCA | I | TEAS CHANGE OF CORRESPONDENCE RECEIVED | Loading... |
| Jun 18, 2001 | ABN2 | O | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE | Loading... |
| Oct 22, 1999 | CNRT | F | NON-FINAL ACTION MAILED | Loading... |
| Oct 20, 1999 | CNEA | F | EXAMINER'S AMENDMENT MAILED | Loading... |
| Oct 14, 1999 | CNEA | F | EXAMINER'S AMENDMENT MAILED | Loading... |
| Feb 19, 1999 | CNRT | F | NON-FINAL ACTION MAILED | Loading... |
| Feb 9, 1999 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Oct 19, 1998 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
Detailed Classifications
Class 005
Pharmaceuticals for therapeutic and diagnostic uses in the treatment of cardiovascular disease, immune disorders, and inflammation; vaccines and purified proteins for therapeutic and medical diagnostic use
First Use Anywhere:
0
First Use in Commerce:
0
Class 040
Custom synthesis of proteins, polynucleotides and biomolecules to the order and specification of others
First Use Anywhere:
0
First Use in Commerce:
0
Class 042
Scientific research and pre-clinical assay services, and pharmaceutical testing
First Use Anywhere:
0
First Use in Commerce:
0
Classification
International Classes
005
040
042